INPATIENT ANTITHROMBOTIC THERAPY FOR MYOCARDIAL INFARCTION : RETROSPECTIVE STUDY
DOI:
https://doi.org/10.57213/jrikuf.v3i3.762Keywords:
antithrombotic, STEMI, NSTEMIAbstract
Myocardial infarction (MI), a subtype of coronary heart disease (CHD), is still a major cause of morbidity and mortality around the world. Non-ST-segment elevation MI (NSTEMI) is more common than ST-segment elevation MI (STEMI). Antithrombotic therapy, including antiplatelet and anticoagulant agents, is essential in MI management to prevent thrombus formation and reduce ischemic complications. Although international and national clinical guidelines (PERKI and ACC/AHA) provide recommendations tailored to MI type and patient factors, discrepancies in clinical practice, especially in developing countries, may impact treatment outcomes. This retrospective descriptive study aimed to evaluate the use and appropriateness of antithrombotic therapy in NSTEMI and STEMI patients at Hospital X, Kediri City, in 2018. Data were collected from medical records of hospitalized acute myocardial infarction (AMI) patients. Aspirin combined with clopidogrel was the most commonly used regimen for NSTEMI, whereas STEMI patients frequently received aspirin, clopidogrel, and enoxaparin; fibrinolytics were administered in nine STEMI cases. Dosage evaluation showed compliance with guidelines in NSTEMI patients, while 36.84% of STEMI patients, particularly those receiving enoxaparin, were given incorrect dosages. These findings highlight the need for improved adherence to clinical guidelines to optimize antithrombotic therapy outcomes in MI management
References
Alquwaizani, M., Buckley, L., Adams, C., & Fanikos, J. (2013). Anticoagulants: A Review of the Pharmacology, Dosing, and Complications. Current Emergency and Hospital Medicine Reports, 1(2), 83–97. https://doi.org/10.1007/s40138-013-0014-6
Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., Pearle, D. L., Sloan, M. A., Smith, S. C. J., Anbe, D. T., Kushner, F. G., Ornato, J. P., Jacobs, A. K., Adams, C. D., Anderson, J. L., … Yancy, C. W. (2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collabora. Circulation, 117(2), 296–329. https://doi.org/10.1161/CIRCULATIONAHA.107.188209
Association, S. L. H., & Forum, S. L. S. (2015). STEMI Management Guidelines. Journal of the Ceylon College of Physicians. https://doi.org/10.4038/jccp.v45i1-2.7734
Badimon, L., Padró, T., & Vilahur, G. (2012). Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. European Heart Journal. Acute Cardiovascular Care, 1(1), 60–74. https://doi.org/10.1177/2048872612441582
Baig, M. F. A., & Chaliki, K. (2024). Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study. Annals of Hematology, 103(9), 3443–3451. https://doi.org/10.1007/s00277-024-05913-7
Benjamin, S., Catherine, J., & Andrew, R. G. (2024). GLOBAL PREVALENCE OF CORONARY ARTERY DISEASE: AN UPDATE FROM THE GLOBAL BURDEN OF DISEASE STUDY. JACC, 83(13_Supplement), 2320. https://doi.org/10.1016/S0735-1097(24)04310-9
Cannon, C. P., Bahit, M. C., Haugland, M. J., Henry, T. D., Schweiger, M. J., McKendall, G. R., Shah, P. K., Murphy, S., Gibson, M. C., McCabe, C. H., Antman, E. M., & Braunwald, E. (2002). Underutilization of Evidence-Based Medications in Acute ST Elevation Myocardial Infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. Critical Pathways in Cardiology, 1(1). https://journals.lww.com/critpathcardio/fulltext/2002/03000/underutilization_of_evidence_based_medications_in.7.aspx
Cohen, M., i Díez, J. E. B., Levine, G. N., Ferguson, J. J., Morrow, D. A., Rao, S. V, & Zidar, J. P. (2007). Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. The Journal of Invasive Cardiology, 19 12, 525–540. https://api.semanticscholar.org/CorpusID:27651657
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., Gale, C. P., Gilard, M., Jobs, A., Jüni, P., Lambrinou, E., Lewis, B. S., Mehilli, J., Meliga, E., Merkely, B., … Siontis, G. C. M. (2021). 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42(14), 1289–1367. https://doi.org/10.1093/eurheartj/ehaa575
Danchin, N., Carda, R., Chaib, A., Lepillier, A., & Durand, E. (2009). Optimizing outcomes in patients with STEMI: mortality, bleeding, door-to-balloon times, and guidelines: the approach to regional systems for STEMI care: defining the ideal approach to reperfusion therapy based on recent trials. European Heart Journal Supplements, 11(suppl_C), C25–C30. https://doi.org/10.1093/eurheartj/sup007
de Veer, A. J. W. M., Bennaghmouch, N., Dewilde, W. J. M., & Ten Berg, J. M. (2021). How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 29(3), 135–141. https://doi.org/10.1007/s12471-020-01500-3
Domei, T., Yamamoto, K., Natsuaki, M., Watanabe, H., Morimoto, T., Obayashi, Y., Nishikawa, R., Kimura, T., Ando, K., Suwa, S., Isawa, T., Takenaka, H., Ishikawa, T., Tamura, T., Kawahatsu, K., Hayashi, F., Abe, M., Serikawa, T., Mori, H., … investigators, the S.-3. (2025). Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial. European Heart Journal - Cardiovascular Pharmacotherapy, 11(2), 198–209. https://doi.org/10.1093/ehjcvp/pvaf002
Felix, B., Aldoohan, F., Kadirage, H. U., Keelathara Sajeev, S., Kayani, M., Hag Saeed, M. A. I., Vempatapu, S., Nasim, K., Pendem, H., Armenta, A. P., & Nazir, Z. (2024). Assessment of the Impact of Comorbidities on Outcomes in Non-ST Elevation Myocardial Infarction (NSTEMI) Patients: A Narrative Review. Cureus, 16(7), e65568. https://doi.org/10.7759/cureus.65568
Fragasso, G., Corti, A., Loiacono, F., Margonato, A., & D’Angelo, A. (2015). Oral direct thrombin inhibition: a double-edged sword? Heart, Lung and Vessels, 7(3), 191–197.
Geravandi, M., Nourabi, M., Navabifar, S., Geravandi, M., Hooshanginezhad, Z., Zand, S., & Taheri, P. (2024). A comparison of the effects of ticagrelor and clopidogrel in patients with acute ST-segment elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. BMC Pharmacology and Toxicology, 25(1), 93. https://doi.org/10.1186/s40360-024-00817-8
Ginanjar, I., Puspaningrat, L. P. D., & Candra, I. G. N. P. (2022). Studi Penggunaan Obat Infark Miokard Akut di Instalasi Rawat Inap Rumah Sakit XYZ Jakarta. Jurnal Farmasi Kryonaut, 1(1), 32–36. https://doi.org/10.59969/jfk.v1i1.7
Hermanides, R. S., Kilic, S., & van ’t Hof, A. W. J. (2018). Optimal pharmacological therapy in ST-elevation myocardial infarction-a review : A review of antithrombotic therapies in STEMI. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 26(6), 296–310. https://doi.org/10.1007/s12471-018-1112-6
Hoekstra, J. W. (2009). The 2007 ACC / AhA STeMI GuIdelIneS : ProvIdInG The BeST AnTIPlATeleT And AnTIThroMBIn MAnAGeMenT of ST-SeGMenT elevATIon MyoCArdIAl InfArCTIon In The ed. https://api.semanticscholar.org/CorpusID:9910650
Huisman, M. V. (2021). Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention. In Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (Vol. 29, Issue 3, pp. 119–120). https://doi.org/10.1007/s12471-021-01546-x
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P., & Widimský, P. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Soci. European Heart Journal, 39(2), 119–177. https://doi.org/10.1093/eurheartj/ehx393
Jayaraj, J. C., Davatyan, K., Subramanian, S. S., & Priya, J. (2018). Epidemiology of Myocardial Infarction. In B. Pamukçu (Ed.), Myocardial Infarction. IntechOpen. https://doi.org/10.5772/intechopen.74768
Layne, K., & Ferro, A. (2017). Antiplatelet Therapy in Acute Coronary Syndrome. European Cardiology Review 2017;12(1):33–7. https://doi.org/10.15420/ecr.2016:34:2
Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., Lindley, K. J., Vaccarino, V., Wang, T. Y., Watson, K. E., & Wenger, N. K. (2016). Acute Myocardial Infarction in Women. Circulation, 133(9), 916–947. https://doi.org/10.1161/CIR.0000000000000351
Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H., Zhao, F., Chrolavicius, S., Copland, I., & Fox, K. A. (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (London, England), 358(9281), 527–533. https://doi.org/10.1016/s0140-6736(01)05701-4
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., Huffman, M. D., Isasi, C. R., Jiménez, M. C., Judd, S. E., Kissela, B. M., Lichtman, J. H., Lisabeth, L. D., Liu, S., … Turner, M. B. (2016). Heart Disease and Stroke Statistics—2016 Update. Circulation, 133(4), e38–e360. https://doi.org/10.1161/CIR.0000000000000350
Nguyen, M., Lem, C., Khatibi, P., Diep, P., Rikimaru, A., Royer, T., & Amin, A. (2011). The use of low-molecular-weight heparins in acute coronary syndromes. Clinical Medicine Reviews in Vascular Health, 3(1), 1–10. https://doi.org/10.4137/CMRVH.S1585
Nozewski, J., Grzesk, G., Klopocka, M., Wicinski, M., Nicpon-Nozewska, K., Konieczny, J., & Wlodarczyk, A. (2021). Management of patient with simultaneous overt gastrointestinal bleeding and myocardial infarction with ST-segment elevation - priority endoscopy. Vascular Health and Risk Management, 17, 123–133. https://doi.org/10.2147/VHRM.S292253
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E. J., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., Granger, C. B., Krumholz, H. M., Linderbaum, J. A., Morrow, D. A., Newby, L. K., Ornato, J. P., Ou, N., Radford, M. J., Tamis-Holland, J. E., … Yancy, C. W. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127(4), e362-425. https://doi.org/10.1161/CIR.0b013e3182742cf6
Pandani, N. W. P., Indrajaya, T., & Syakurah, R. A. (2018). Obat-Obat Antitrombotik yang Digunakan pada Pasien Infark Miokard Akut di Rsup Mohammad Hoesin Palembang. Biomedical Journal of Indonesia, 4(3), 106–111.
Patra, V., & Ulchala, V. E. (2018). Role of clopidogrel in addition to aspirin in the prevention of recurrent ischaemic events in acute coronary syndrome with ST-segment elevation. International Journal of Basic & Clinical Pharmacology, 7(8), 1506. https://doi.org/10.18203/2319-2003.ijbcp20183002
PERKI. (2018). Pedoman Tata Laksana Sindrom Koroner Akut. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, 4. https://doi.org/10.5694/j.1326-5377.2007.tb01292.x
PERKI. (2024). Pedoman Tata Laksana Sindrom Koroner Akut 2024. 5. www.merckmanuals.com/professional/cardiovascular_
Piccolo, R., Manzi, L., Simonetti, F., Leone, A., Angellotti, D., Immobile Molaro, M., Verde, N., Cirillo, P., Di Serafino, L., Franzone, A., Spaccarotella, C. A., & Esposito, G. (2023). Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease. In Journal of Clinical Medicine (Vol. 12, Issue 7). https://doi.org/10.3390/jcm12072572
Rahman, M. M., Ali, M. A., Ahmed, F. U., Noor, H., Kabir, S. M. E. J., & Uddin, M. G. (2024). Efficacy and Safety of Fondaparinux Versus Enoxaparin in The Management of Unstable Angina and NSTEMI. Bangladesh Heart Journal, 39(1), 31–37. https://doi.org/10.3329/bhj.v39i1.70709
Rao, S. V, O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., Davis, L. L., de Lemos, J. A., DeWald, T. A., Elgendy, I. Y., Feldman, D. N., Goyal, A., Isiadinso, I., Menon, V., Morrow, D. A., … Williams, M. S. (2025). 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. In Circulation. https://doi.org/10.1161/CIR.0000000000001309
Saito, Y., Oyama, K., Tsujita, K., Yasuda, S., & Kobayashi, Y. (2023). Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. Journal of Cardiology, 81(2), 168–178. https://doi.org/10.1016/j.jjcc.2022.07.003
Salari, N., Morddarvanjoghi, F., Abdolmaleki, A., Rasoulpoor, S., Khaleghi, A. A., Hezarkhani, L. A., Shohaimi, S., & Mohammadi, M. (2023). The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders, 23(1), 206. https://doi.org/10.1186/s12872-023-03231-w
Showkathali, R., & Natarajan, A. (2012). Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review. Current Cardiology Reviews, 8(3), 239–249. https://doi.org/10.2174/157340312803217193
Sobieszczyk, P. (2008). Guidelines and Performance Measures for the Management of Acute Coronary Syndrome. In Journal of Managed Care Pharmacy : JMCP (Vol. 14, Issue 6 Suppl A). https://doi.org/10.18553/jmcp.2008.14.S6-A.4
Streiff, M. B. (2023). Perioperative Management of Anticoagulation and Antithrombotic Therapy. Journal of the National Comprehensive Cancer Network, 21(Supplement), 37–39. https://doi.org/10.6004/jnccn.2023.5042
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018). Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology, 72(18), 2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038
Toyota, T., Watanabe, H., Kim, K., Furukawa, Y., & Kimura, T. (2025). Antithrombotic Therapy for Acute Coronary Syndrome. Journal of Neuroendovascular Therapy, 19(1). https://doi.org/10.5797/jnet.ra.2024-0102
Tran, H., Mehta, S. R., & Eikelboom, J. W. (2006). Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). Vascular Health and Risk Management, 2(4), 379–387. https://doi.org/10.2147/vhrm.2006.2.4.379
Ullah, R., Khawaja, I., Khan, R. U., Murad, L., Murad, A., & Ahmad, W. (2023). Risk stratification and anticoagulation strategies for post-PCI management in acute myocardial infarction patients with severe left ventricular dysfunction. International Journal of Health Sciences, 7(S1), 651–661. https://doi.org/10.53730/ijhs.v7nS1.14249
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F.-J., Petricevic, M., Roffi, M., Steg, P. G., Windecker, S., Zamorano, J. L., & Levine, G. N. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European. European Heart Journal, 39(3), 213–260. https://doi.org/10.1093/eurheartj/ehx419
Valgimigli, M., Frigoli, E., Heg, D., Tijssen, J., Jüni, P., Vranckx, P., Ozaki, Y., Morice, M.-C., Chevalier, B., Onuma, Y., Windecker, S., Tonino, P. A. L., Roffi, M., Lesiak, M., Mahfoud, F., Bartunek, J., Hildick-Smith, D., Colombo, A., Stanković, G., … Smits, P. C. (2021). Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. The New England Journal of Medicine, 385(18), 1643–1655. https://doi.org/10.1056/NEJMoa2108749
Valizadeh, A., Soltanabadi, S., Koushafar, S., Rezaee, M., & Jahankhah, R. (2020). Comparison of QT dispersion in patients with ST elevation acute myocardial infarction (STEMI) before and after treatment by streptokinase versus primary percutaneous coronary intervention (PCI). BMC Cardiovascular Disorders, 20(1), 493. https://doi.org/10.1186/s12872-020-01767-9
Verheugt, F. W. A. (2009). Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction. Circulation, 119(24), 3047–3049. https://doi.org/10.1161/CIRCULATIONAHA.109.873778
Vogel, R. F., Delewi, R., Badimon, L., Angiolillo, D. J., & Vlachojannis, G. J. (2022). Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI. Reviews in Cardiovascular Medicine, 23(9), 297. https://doi.org/10.31083/j.rcm2309297
Yamazaki, M. (2020). Monitoring of Antithrombotic Therapy. Journal of Atherosclerosis and Thrombosis, 27(3), 201–203. https://doi.org/10.5551/jat.ED120
Yusuf, S., Zhao, F., Mehta, S. R., Chrolavicius, S., Tognoni, G., & Fox, K. K. (2001). Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The New England Journal of Medicine, 345(7), 494–502. https://doi.org/10.1056/NEJMoa010746
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jurnal Riset Ilmu Kesehatan Umum dan Farmasi (JRIKUF)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
